Antitumor activity of cordycepin in murine malignant tumor cell line: An in vitro and in silico study
Graphical abstract
Introduction
Cordyceps militaris is an entomopathogenic fungus that grows on the larvae or pupae of insects and it belongs to the phylum Ascomycota, class Sordariomycetes and family Cordycipitaceae [1]. It is locally known as keeda ghas and in China, it is popularly called Dong-Chong-Xia-Cao which translates as winter worm summer grass [2]. In Ayurveda, cordyceps is considered a rasayana herb, which means it is believed to possess rejuvenating properties for prana, the life force. It promotes the well-being of the endocrine system and provides nourishment to the adrenal and reproductive glands. The use of Cordyceps sp. has garnered immense public attention in recent years because of its high price tag and rare availability as it is found at an altitude of approximately 14,000 ft in the Himalayan lands including Nepal, China, Tibet, and India [3,4]. This parasitic mushroom has been well-known in several other traditional medicines for several thousand years for exhibiting a multitude of pharmacological functions such as antioxidant, antitumor, antimetastatic, anti-inflammatory activities, immunopotentiation, immunosuppression, renoprotection, lung and liver protection, etc. [5,6,7,8].
C. militaris has a lot of bioactive compounds that give it medicinal and healing qualities. These include polysaccharides, essential amino acids, fats, flavonoids, phenolic substances, carotenoids, sterols, nucleosides, sterols, proteins, minerals, vitamins, etc. [9,10,4]. One of its potent active compounds, cordycepin or 3′-deoxyadenosine (9-(3-deoxy-β-d-ribofuranosyl) adenine), a nucleoside analogue (Fig. 1) was first extracted from Cordyceps militaris [11]. A purine (adenine) nucleoside and a ribose sugar (ribofuranose) moiety are joined together in the chemical structure of cordycepin via a β-N9-glycosidic bond. The chemical conflation of cordycepin is achieved through the replacement of the OH group at the 3′ position in the ribofuranosyl moiety with H, generating a deoxy analogue of adenosine [5,12]. Within the cellular realm, cordycepin undergoes a remarkable transformation, metamorphosing into 5′ mono-, di-, and tri-phosphates that inhibit the activity of specific enzymes, such as ribose phosphate pyrophosphokinase and 5-phosphoribosyl-1-pyrophosphate amidotransferase, which are used in the de novo biosynthesis of purines [13]. The presence of cordycepin in the cell causes premature termination of transcription due to the inclusion of cordycepin/ 3′-deoxyadenosine instead of adenosine during transcription due to their structural similarities [14]. Cordycepin is reported to possess many biological and pharmacological activities including anticancer, antiviral, immunostimulating activities, antithrombotic, anti-adipogenic, anti-ageing effects, etc. [6,15,16,17]. It is known to interfere with several biochemical and molecular processes, such as purine biosynthesis [13], DNA/RNA synthesis [14], and mTOR (mammalian _target of rapamycin) signaling transduction [18]. Therefore, in the past few decades, extensive research works using cordycepin have been carried out in different countries which has necessitated its large-scale production and this ever-increasing demand is being successfully met by lab based artificial cultivation of C. militaris [19,20]. The artificially grown cordyceps are also reported to show the same promising results and contain almost the same biochemical constituents like the natural ones [21].
Despite the significant role played by cordycepin in the anti-tumor activities the mechanism(s) by which cordycepin inhibits tumor growth is not yet clearly understood [22,23]. Hence, in the present study, the anticancer potential of cordycepin has been reported using cytotoxicity and apoptosis parameters in Dalton's lymphoma (DL) malignant cancer cell line. The findings were supported further by in silico investigations that included molecular docking simulation followed by molecular dynamics. Based on our findings, cordycepin may be a promising pharmacological candidate for the treatment of the most dreadful cancer.
Section snippets
Cell culture and drug preparation
The DL cells were cultured in RPMI/DMEM medium supplemented with a blood product, fetal bovine serum (10% v/v), streptomycin (100 μg/mL), and penicillin (100 U/mL). The cell lines were maintained in a CO2 incubator (Eppendorf, USA) at 37 °C with 5% CO2. Cordycepin (Cat. No: BP0392) was purchased (purity: 98%, HPLC-DAD, 260 nm) from Chengdu Biopurify Phytochemicals Ltd., Wenjiang District, Chengdu, Sichuan Province, China- 611130. To prepare the stock for different doses of cordycepin, 1 mg of
Cell viability assay
The cytotoxicity of cordycepin was evaluated on DL cells by using trypan blue assay and comparing them to a no-treatment control and cisplatin (reference drug). The basic principle of TBE assay is that live cells possess intact cell membranes that exclude the dye whereas in dead cells the dye penetrates into its membranes and shows blue coloured cytoplasm when observed under a light microscope [34]. The DL cells were treated with various concentrations (0.01–1.2 mg/ml) for 24 hrs (Fig. 2). The
Conclusion
The antitumor activities of cordycepin (in vitro) considering cell cytotoxicity study by performing trypan blue assay and apoptosis studies carried out by dual staining method using acridine orange and ethidium bromide (AO/EB) revealed that cordycepin significantly induced cell cytotoxicity in concentration dependent manner in DL cancer cells by causing apoptotic cell death. The molecular docking simulation of cordycepin with antiapoptotic receptor proteins revealed that cordycepin shows
CRediT authorship contribution statement
Jumi Das: Writing – original draft, Investigation. M. Qaiser Fatmi: Software, Formal analysis, Methodology, Conceptualization. Mary Devi: Investigation. Namram Sushindrajit Singh: Data curation, Software, Methodology, Conceptualization. Akalesh Kumar Verma: Supervision, Conceptualization, Methodology, Writing – review & editing.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
Jumi Das acknowledges the Department of Biotechnology (DBT), Government of India for using resources of ongoing DBT project (no. BT/INF/22/SP45376/2022) in the present work. Additionally, we would like to express our gratitude to Cotton University's Faculty of Life Sciences for providing the animal housing facility.
References (54)
- et al.
Quality control of Cordyceps sinensis, a valued traditional Chinese medicine
J. Pharm. Biomed. Anal.
(2006) - et al.
Cordycepin: a bioactive metabolite with therapeutic potential
Life Sci.
(2013) Cordyceps–a traditional Chinese medicine and another fungal therapeutic biofactory?
Phytochemistry
(2008)- et al.
Medicinal uses of the mushroom Cordyceps militaris: current state and prospects
Fitoterapia
(2010) - et al.
Effect of cordycepin on interleukin-10 production of human peripheral blood mononuclear cells
Eur. J. Pharmacol.
(2002) - et al.
Optimization of carbon source and carbon/nitrogen ratio for cordycepin production by submerged cultivation of medicinal mushroom Cordyceps militaris
Process Biochem.
(2005) - et al.
Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction
J. Biol. Chem.
(2010) - et al.
Production of cordycepin by a repeated batch culture of a Cordyceps militaris mutant obtained by proton beam irradiation
J. Biosci. Bioeng.
(2011) - et al.
In vitro evaluation of antioxidant activities of aqueous extracts from natural and cultured mycelia of Cordyceps sinensis
LWT-Food Sci. Technol.
(2008) - et al.
Antiproliferative evaluation and supramolecular association in Mn (II) and Zn (II) bipyridine complexes: combined experimental and theoretical studies
J. Inorg. Biochem.
(2019)
Structural-based virtual screening and identification of novel potent antimicrobial compounds against YsxC of Staphylococcus aureus
J. Mol. Struct.
(2022)
GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers
SoftwareX
(2015)
Phenanthroline-based Ni (II) coordination compounds involving unconventional discrete fumarate-water-nitrate clusters and energetically significant cooperative ternary π-stacked assemblies: antiproliferative evaluation and theoretical studies
J. Mol. Struct.
(2022)
Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of the estrogen receptor
Toxicol. Appl. Pharmacol.
(2011)
Structure of dye-decolorizing peroxidase from Bacillus subtilis in complex with veratryl alcohol
Int. J. Biol. Macromol.
(2021)
GHKL, an emergent ATPase/kinase superfamily
Trends Biochem. Sci.
(2000)
Independent ATPase activity of Hsp90 subunits creates a flexible assembly platform
J. Mol. Biol.
(2004)
Development of high cordycepin-producing Cordyceps militaris strains
Mycobiology
(2017)
Estimation of cordycepin by improved HPLC method in the natural and cultured mycelia of high medicinal value Himalayan entomogenous fungus Cordyceps sinensis
Electron. J. Environ. Agricult. Food Chem.
(2010)
Comparison of major bioactive compounds of the caterpillar medicinal mushroom, Cordyceps militaris (Ascomycetes), fruiting bodies cultured on wheat substrate and pupae
Int. J. Med. Mushroom.
(2016)
Cordycepin: selective growth inhibitor derived from liquid culture of Cordyceps m ilitaris against clostridium spp
J. Agric. Food Chem.
(2000)
Chemical ingredients of Cordyceps militaris
Mycobiology
(2008)
Advances in research of polysaccharides in Cordyceps species
Food Technol. Biotechnol.
(2009)
Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) link
Nature
(1950)
Preparative separation of high-purity cordycepin from Cordyceps militaris (L.) link by high-speed countercurrent chromatography
J. Liq. Chromatogr. Relat. Technol.
(2011)
The Inhibition of Phosphoribosyl-Pyrophosphate Amidotransferase Activity By Cordycepin Monophosphate
(1964)
Cordycepin interferes with 3′ end formation in yeast independently of its potential to terminate RNA chain elongation
RNA
(2009)
Cited by (2)
Cosmeceutical Applications of Cordyceps
2024, Advances in Cordyceps Research: Prospects and Avenues
© 2023 Elsevier B.V. All rights reserved.